Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

We created an international registry of IBD patients who developed COVID-19. Corticosteroids, but not TNF antagonists, were associated with adverse outcomes. Other risk factors were similar to the general population.